A new analysis conducted by Forbes puts grim numbers on new drug development costs. A company hoping to get a single drug to market can expect to have spent $350 million before the medicine is available for sale. In part because so many drugs fail, large pharmaceutical companies that are working on dozens of drug projects at once spend $5 billion per new medicine. Some caveats, though: drug companies have tax incentives to count costs in research and development, which could inflate the figure; they also are likely to spend extra money in order to get those medicines approved in other countries.
So you spent a lot of time and money getting your target audience to ask for your medication and get an Rx, but that may not be enough. Some insurers want to talk to the prescribing physician to ensure that they have tried generic medications first and to understand why the physiciam is prescribing a branded medication. DTC marketrs need to understand the potential barracades for patients seeking branded prescription drugs.